U.S. Renewable Energy Stock News

Short term stock performance check Kodiak AI (KDK) has been on many watchlists after a weak share performance, with the stock down about 3% over the past week and about 17% over the past month. Looking further back, the stock has declined about 23% over the past 3 months and about 40% over the past year. This provides additional context for anyone tracking shorter term shifts. See our latest analysis for Kodiak AI. With the share price at $6.88 and the 1 year total shareholder return down...

Torrid Holdings (CURV) opened Q1 2027 with total revenue of US$245.8 million, basic EPS of roughly US$0.00, net income of US$0.4 million and same store sales that fell 1.7% year over year. Over recent quarters the company has seen revenue move from US$265.97 million in Q1 2026 to US$245.8 million in Q1 2027, while basic EPS shifted from about US$0.06 in Q1 2026 to roughly US$0.00 in the latest quarter. With the trailing twelve month line still showing a loss and revenue effectively flat, this...

Ferrellgas Partners (OTCPK:FGPR) has just posted its Q2 2026 numbers, with revenue of US$641.4 million and basic EPS of US$2.51. The trailing twelve month figures show revenue of about US$1.9 billion and basic EPS of US$1.31, as earnings have shifted from earlier losses into profit over the past year. Over recent quarters, revenue has ranged from US$343.6 million to US$669.8 million and basic EPS has swung between a loss of US$18.83 and a profit of US$2.51. This sets up a story where margins...

Exelixis reported new phase 3 CABINET trial data for CABOMETYX in advanced neuroendocrine tumors. The subgroup analysis showed significant improvements in progression free survival regardless of tumor functional status. These data were presented at ASCO 2026 and expand the evidence base for CABOMETYX in neuroendocrine tumors. For investors following NasdaqGS:EXEL, the CABINET subgroup results arrive with the stock at $52.7 and strong recent returns, including 20.9% year to date and 22.5%...

Recent stock performance and business context Arcus Biosciences (RCUS) has drawn attention after recent share price moves, with the stock down 6.1% on the day and about 10.8% over the past month, while still up over the past 3 months. At a recent close of US$23.19 and a market value of around US$3.1b, the company remains a clinical stage cancer therapy developer with revenue of US$236.0m and a reported net loss of US$369.0m. See our latest analysis for Arcus Biosciences. Recent moves have...

Recently, Zacks Investment Research upgraded Sharplink Inc. (SBET) to a Rank #2 (Buy), citing an upward trend in the company’s earnings estimates. This reassessment of Sharplink’s earnings outlook highlights how revisions in expectations can influence investor perception of the business’s longer-term potential. Next, we’ll explore how this improved earnings outlook, reflected in the Zacks upgrade, shapes Sharplink’s broader investment narrative. Invest in the nuclear renaissance through our...

Paramount Skydance's acquisition of Warner Bros. Discovery (NasdaqGS:WBD) is moving through global regulatory reviews, including a formal process in Europe. U.S. attorneys general are examining potential competition and industry impacts from the proposed Hollywood combination. Warner Bros. Discovery has reported a profitable streaming segment and recorded a substantial, one off merger related fee that resulted in a large loss. Warner Bros. Discovery, the media and entertainment group behind...

Wondering whether NVR at around US$6,182 per share is offering fair value or an opportunity? This article looks at what the current price really reflects. The stock has edged up 1.3% over the past week and 1.4% over the past month, yet is still down 15.1% year to date and 13.1% over the last year. This naturally raises questions about how the market is assessing its prospects and risks. Recent attention on NVR has focused on its broader sector context and housing market conditions, with...

PENN Entertainment (NasdaqGS:PENN) is opening the new US$360 million Hollywood Casino Aurora as its latest land-based flagship in Illinois. The long-running Hollywood Casino riverboat in Aurora is set to close after more than 30 years of operation as activity shifts to the new property. The new complex combines gaming, hotel rooms, dining, and entertainment offerings in a single, purpose-built facility. The move reflects PENN Entertainment's push to grow its brick and mortar footprint...

If you are wondering whether AllianceBernstein Holding at around US$37.19 is attractively priced or asking too much for future returns, the starting point is understanding what the current valuation is actually baking in. The stock has been relatively steady over the past week with a 0.5% gain, while it has fallen 7.8% over the last month, is down 3.8% year to date, yet still shows a 2.4% return over one year, 39.4% over three years and 24.1% over five years. Recent coverage has focused on...

Wondering if First Financial Bankshares at around US$32.35 is offering value or asking too much of your capital? This article focuses squarely on what the current share price might imply about the stock. The share price is up 7.8% year to date, even though the stock has fallen 1.1% over the last week and 7.0% over the past year, with a 29.9% decline across five years and a 17.2% gain across three years adding more mixed signals. Recent coverage has focused on the bank's positioning in its...

Bausch + Lomb (NYSE:BLCO) has launched Blink Triple Care Preservative Free eye drops in the U.S. The product is a preservative free, long lasting dry eye treatment available in a multi dose bottle. The launch expands the Blink brand within the competitive U.S. dry eye market. Bausch + Lomb, a long standing player in eye health, is adding Blink Triple Care Preservative Free to its U.S. product portfolio at a time when dry eye treatments are drawing more consumer attention. Patients and eye...

Calvin B. Taylor Bankshares (TYCB) kicked off Q1 2026 with total revenue of US$9.7 million and net income of US$3.8 million, translating into basic EPS of US$1.44, compared with Q1 2025 levels of US$9.6 million in revenue and US$3.7 million of net income, or EPS of US$1.36. Over the last twelve months, revenue has moved from US$35.7 million to US$39.2 million, while net income has gone from US$13.8 million to US$15.5 million and EPS has stepped up from US$5.05 to US$5.74. This gives investors...

Fluor (NYSE:FLR) received a US$1.03b contract modification from the U.S. Naval Sea Systems Command. The award supports the Naval Nuclear Laboratory and expands Fluor’s role in a major naval nuclear propulsion program. The contract modification is structured as a multi-year assignment focused on critical government work. For investors watching NYSE:FLR, this contract modification adds a large, long-duration project in U.S. defense alongside the company’s existing LNG and infrastructure work...

If you are wondering whether Parker-Hannifin's current share price reflects its true value, the recent performance gives you plenty to think about. The stock recently closed at US$872.23, with a 7 day gain of 2.3%, a 30 day move that is roughly flat at a 0.1% decline, a year to date decline of 2.4%, and a 1 year return of 32.9% alongside very large 3 year and 5 year returns of 153.1% and 206.9% respectively. These returns sit against a backdrop of ongoing interest in Parker-Hannifin as a...

Recent price moves and what they might signal PayPay (PAYP) has seen its share price fall 7.7% today, extending a decline of about 20% over the past week and 26% over the past month, putting recent performance firmly in focus for investors. See our latest analysis for PayPay. The recent drop sits within a wider loss of momentum, with the share price return year to date down 13.33%, suggesting investors are reassessing both PayPay’s growth profile and the risks they are prepared to accept at...

If you are wondering whether Warner Music Group at around US$30 per share still offers value, or if the easier upside has already been taken, this article breaks down what the current price might be implying. The stock has pulled back around 7.3% over the last week. It is still up about 17.3% over the past year, which can change how you think about both upside potential and risk. Recent coverage has focused on Warner Music Group as a key listed player in the global recorded music and...

If you are wondering whether Oracle's share price still makes sense after a strong run, this article walks through what the current valuation actually implies for you. At a last close of US$236.34, Oracle's stock has delivered returns of 16.0% over 7 days, 27.5% over 30 days, 20.8% year to date, 39.5% over 1 year, 127.8% over 3 years and 207.3% over 5 years. Recent coverage has focused on Oracle's role in software and cloud infrastructure, and how its positioning in these areas may be...

Intuitive Machines has been awarded the multi billion dollar Andromeda contract by the U.S. Space Force, marking a major move into national security space infrastructure. The company also announced the acquisitions of Goonhilly Earth Station in the U.K. and COMSAT in the U.S., expanding its global space to ground communications network. These developments broaden Intuitive Machines' reach across commercial, civil, and government markets and increase its global operational footprint. For...

REalloys (ALOY) is back in focus after signing a non-binding Letter of Intent with Patriot Exploration & Mining, giving the rare earth specialist potential priority access to a sizeable U.S. magnet-metal resource. See our latest analysis for REalloys. The latest LOI comes on the heels of REalloys’ recent MOU with Ramaco Resources and news of its inclusion in the Russell 3000 Index. The stock has shown a 42.16% year to date share price return and a very large 1 year total shareholder return,...

Healthpeak Properties (NYSE:DOC) completed the IPO of its Janus Living platform, generating significant proceeds while keeping majority ownership. Following a strong first quarter, the company raised its 2026 FFOA guidance. These moves mark a material shift in Healthpeak Properties' portfolio mix and capital position compared with prior updates that focused on valuation and stock performance. Healthpeak Properties centers its business on healthcare real estate, which sits at the...

DocuSign (NasdaqGS:DOCU) has launched an Intelligent Agreement Management app, powered by its Iris AI, within OpenAI's ChatGPT and Codex platforms. The company has also appointed Graham Sheldon, a former product leader at UiPath and Microsoft, as its new Chief Product Officer. For investors watching how software providers use AI in real business workflows, DocuSign sits at an interesting crossroads of e-signatures, contract lifecycle tools and broader agreement management. Its new Iris AI...

AM Best recently affirmed the A- (Excellent) Financial Strength Rating and the "a-" Long-Term Issuer Credit Rating of North End Re Ltd. (Bermuda), a subsidiary of Brookfield Wealth Solutions, maintaining a stable outlook based on its strong balance sheet, adequate operating performance, and support from its parent. A key element of this rating affirmation is AM Best’s recognition of North End Re Ltd.’s plans to assume annuity-type business from European and Asian markets, highlighting the...

Zions Bancorporation National Association (NasdaqGS:ZION) has appointed Daniel J. Ryan, a retired PwC partner, to its board of directors. Ryan brings more than 40 years of experience in public banking, governance, risk, and cybersecurity oversight. His appointment expands the board and includes immediate roles on key governance, audit, and risk related committees. Zions Bancorporation, a regional banking company, operates in a sector where regulators and investors pay close attention to...